AirAsia India Announces New Flights, Offers Tickets From Rs 1,699
AirAsia India has announced the introduction of new daily flights from Kolkata to Visakhapatnam, Guwahati, Imphal and Pune, at a starting all-inclusive price of Rs 1,699. Â Bookings for AirAsia India's new flights under this offer are open till April 15, 2018. The flights are scheduled to commence from May 11, 2018, informed AirAsia India on its official website- airasia.com. The travel period under this price offer ends on May 30, 2018. Advance bookings are required in order to avail this promotional offer on new flights, the carrier further said.
Also read:Â Jet Airways, GoAir, AirAsia Latest Discount Offer On Flight Tickets
Â
AirAsia India is offering flight tickets at a starting price of Rs 1,699 on flights between Kolkata and Guwahati, Kolkata and Imphal, Kolkata and Visakhapatnam. Flights between Kolkata and Pune are priced at Rs 3,499. A search on AirAsia India's portal showed flights between Kolkata and Guwahati were priced at Rs 1,699 in May 2018.
Also read:Â AirAsia India Offers Flight Tickets Below Rs. 1,400 On Select Routes
Â
5 things to know about AirAsia India's new daily flights offer:
Â
1. The flight tickets are available only for online bookings at www.airasia.com, noted the airline.
Â
2. Seats are limited and may not be available on all flights, AirAsia India said on its website.
Â
3. Ticket fares includes airport taxes (except for selected airports where airport tax is collected at the point of departure), AirAsia India further.
Â
4. A non-refundable processing fee is applicable for payments via credit, debit or charge card in order to avail the offer, said the carrier.Â
Â
5. The offer is subject to availability and 'AirAsia's Terms and Conditions', mentioned AirAsia India.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.